Section Arrow
IQV.NYSE
- IQVIA Holdings
Quotes are at least 15-min delayed:2025/09/18 04:15 EDT
Pre Market
Last
 --
-- (--)
Bid
172.3
Ask
200.01
High -- 
Low -- 
Volume -- 
Regular Hours
Last
 186.69
-0.12 (-0.06%)
Day High 
191.71 
Prev. Close
186.81 
1-M High
196.22 
Volume 
955.44K 
Bid
172.3
Ask
200.01
Day Low
185.49 
Open
186.95 
1-M Low
177.82 
Market Cap 
31.76B 
Currency USD 
P/E 27.07 
%Yield -- 
10-SMA 186.83 
20-SMA 187.85 
50-SMA 182.74 
52-W High 248.03 
52-W Low 134.645 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
6.90/12.99
Enterprise Value
44.77B
Balance Sheet
Book Value Per Share
33.99
Cash Flow
Cash Flow Yield
0.08
Income Statement
Total Revenue
15.41B
Operating Revenue Per Share
87.38
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BIAFbioAffinity Technologies0.1826-0.0784-30.04%-- 
Pre Market 0.1771 -0.0055 -3.01%
NEOGNeogen Corp5.46+0.19+3.61%879PE
Pre Market -- -- --
DHRDanaher Corp192.94+2.47+1.30%40.44PE
Pre Market -- -- --
NEONeoGenomics8.11+0.12+1.50%-- 
Pre Market -- -- --
CHEKCheck-Cap Ltd2.32-0.2-7.94%-- 
Pre Market 2.15 -0.17 -7.33%
Quotes are at least 15-min delayed:2025/09/18 04:15 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.